Core Points - Sharps Technology, Inc. has successfully closed a secured bridge loan financing of approximately 1,250 in secured notes and shares of common stock for every 4,375,000 in principal amount of notes and 5,700,006 shares of common stock [2] - The net proceeds from the offering will be used for general corporate purposes and working capital [2] Company Overview - Sharps Technology is a medical device and pharmaceutical packaging company that specializes in patented smart-safety syringe products [6] - The company focuses on ultra-low waste capabilities and incorporates both passive and active safety features in its syringe technologies [6] - Sharps Technology has a manufacturing facility in Hungary and is collaborating with Nephron Pharmaceuticals to expand its manufacturing capacity in the U.S. [6]
Sharps Technology, Inc. Closes $3.5 Million Bridge Financing